Position: Medical Doctor
Location: Beijing, CN
Dr. Guo has research interests in the clinical epidemiology and cardiovascular disease (CVD) prevention. She has studied the prevalence, incidence, and lifetime risk of atrial fibrillation (AF) over decades using a large medical insurance data involving in over 10 million Chinese and has examined ethic difference on the disease burden of AF and stroke, effective prevention strategy between European and Chinese populations, leading the Optimal Thrombophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
She has explored the mobile health technology for the primary and secondary prevention of CVD. As PI of the successfully completed Huawei heart Study and Mobile Health technology Improving screening and integrated care (mAFA I, II) randomised trials, the smart technology and artificial intelligence have been applied into the population-based risk screening and integrated care. Now over one million subjects involve in CVD screening (AF, sleep apnoea. etc.) using mAFA in China.
She is FESC, FACC; General Secretary of Cardiology Society, Chinese Society for Geriatric Health; Fellow of Chinese Society of Cardiology Prevention, Chinese Medical Association.